Armonica Technologies
Waneta has 40 years of experience at the intersection of technology and health care. An entrepreneur, executive and experienced board member she brings an innovative spirit, grounded in practical understanding of health care. She holds a Ph.D. and an MBA and has started six companies. She served on the Board of Directors for NASDAQ traded MGI Pharma through its sale to Eisai Pharmaceuticals and she served for ten years (2007-2017) on the Board of Health Care Service Corporation, the nation’s fourth largest health insurer by enrollment. HCSC operates Blue Cross and Blue Shield of Illinois, Montana, New Mexico, Oklahoma and Texas. She also serves as a member of the Advisory Board to Tullis Health Investors of Florida and is a member of the corporation for the Charles Stark Draper Laboratory in Cambridge, Massachusetts.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Armonica Technologies
Armonica Technologies is an early stage medtech company focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications. Armonica’s technology uses proprietary nanochannels to deliver single DNA molecules through nanopores for optical readout by Raman spectroscopy. Armonica’s approach will lead to faster, more thorough, and more accurate genomic analysis than is currently available, without the need for library preparation.